NCR1 and myalgic encephalomeyelitis/chronic fatigue syndrome: In conclusion, this study was unable to validate immune biomarkers in ME/CFS, either alone or in combination with other previously defined markers (such as the tandem NKp46 and CD57), which unfortunately showed a high degree of instability in frozen PBMC samples.